Skip to main content
Figure 6 | Medical Gas Research

Figure 6

From: Defining the minimally effective dose and schedule for parenteral hydrogen sulfide: long-term benefits in a rat model of hindlimb ischemia

Figure 6

7 Day Administration of Na2S is Sufficient to Enhance Blood Flow to the Ischemic Hind Limb, which Persists 3 Weeks After Treatment is Stopped. This graph illustrates day 0, 7, 14, and 28 laser doppler blood flow measurements from the ischemic hind limbs of rats treated with either vehicle or Na2S at 0.25 mg/kg twice daily for 3 days, 0.25 mg/kg twice daily for 7 days, or 0.5 mg/kg once daily for 7 days. * p < 0.05 vs Postligation within the same treatment group by One Way ANOVA. Values are mean ± SEM.

Back to article page